Summit Therapeutics SMMT Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's operating lease right-of-use assets in other assets?
- Summit Therapeutics (SMMT) reported operating lease right-of-use assets in other assets of $19.4M in Q1 2026.
- How has Summit Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Summit Therapeutics's operating lease right-of-use assets in other assets increased by 205.4% year-over-year, from $6.35M to $19.4M.
- What is the long-term trend for Summit Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Summit Therapeutics's operating lease right-of-use assets in other assets has grown at a 106.1% compound annual growth rate (CAGR), from $554K to $20.62M.